Electrochemical determination of acetamiprid using PEDOT sensing coating functionalized with carbon quantum dots and Prussian blue nanoparticles.

A dual-mode electrochemical biosensor for acetamiprid detection was proposed for the first time based on carbon quantum dots/Prussian blue (CQDs/PB)-functionalized poly(3,4-ethylenedioxythiphene) (PEDOT) nanocomposite. The nanocomposite with spherical stacking nanostructure showed high surface area, excellent catalytic ability, and cycling stability. The biosensor can be effortlessly constructed after the immobilization of acetamiprid aptamer. The concentration of acetamiprid can be determined by differential pulse voltammetry (DPV) based on its signal change deduced from the pristine PB. With the capture of acetamiprid, the response current (I-T) signal generated by hydrogen peroxide catalysis from the biosensor can also been used to establish the method for monitoring acetamiprid. The dual-mode biosensor showed a wide linear range from 10-12 g mL-1 to 10-6 g mL-1, low detection limits of 6.84 × 10-13 g mL-1 and 4.99 × 10-13 g mL-1, and ultrafast detection time of 25 s and 5 s through DPV and I-T mode, respectively. The biosensor possessed excellent selectivity and stability. More importantly, the biosensor was successfully applied to detect acetamiprid residues in vegetables, proving a promising approach for routine detection of pesticide in real samples. The biosensor based on PEDOT/CQDs/PB for acetamiprid can be effortlessly constructed through both the increase of differential pulse voltammetry (DPV) signal change deduced by the pristine PB and the decrease of the response current (I-T) signal of the reduction of hydrogen peroxide catalyzed by PEDOT/CQDs/PB.

Treatment evaluation of Rheumatoid arthritis by in situ fluorescence imaging of the Golgi cysteine.

Rheumatoid arthritis (RA) is a long-term systemic inflammatory disease that causes severe joint pain. Golgi stress caused by redox imbalance significantly involves in acute and chronic inflammatory diseases, in which cysteine (Cys), as a representative reducing agent, may be an effective biomarker for RA. Hence, in order to achieve RA early detection and drugs evaluation, based on our previous work about innovative Golgi-targeting group, we established a phenylsulfonamide-modified fluorescence probe, Golgi-Cys, for the selective fluorescence imaging of Cys in Golgi apparatus in vivo. By application of Golgi-Cys, the Cys changes under Golgi stress in cells were elucidated. More importantly, we found that the probe can be effectively utilized for the RA detection and treatment evaluation in situ.